(n) A provider network that is organized pursuant to part 3 of article 18 of title 6 and includes persons licensed under article 240 of this title 12 or advanced practice registered nurses;
(o) A health system that includes two or more authorized entities with a common governing board;
(p) A trust organization established under article 70 of title 11;
(q) An entity licensed pursuant to parts 1 and 4 of article 16 of title 10;
(r) An accountable care organization established under the federal “Patient Protection and Affordable Care Act”,
Pub.L. 111-148, as amended, or other organization with a similar function;
(t) An ambulatory surgical center licensed pursuant to part 1 of article 3 of title 25.
(6) The medical board and the nursing board, with respect to the licensees subject to their jurisdiction, may establish by rule procedures necessary to authorize other health care or physician organizations or professional societies as authorized entities that may establish professional review committees.
(7)(a) A professional review committee acting pursuant to this part 2 may investigate or cause to be investigated:
(I) The qualifications and competence of any person licensed under article 240 of this title 12 or any advanced practice registered nurse who seeks to subject himself or herself to the authority of any authorized entity; or
(II) The quality or appropriateness of patient care rendered by, or the professional conduct of, any person licensed under article 240 of this title 12 or any advanced practice nurse who is subject to the authority of the authorized entity.
(b) The professional review committee shall conduct the investigation in conformity with written bylaws, policies, or procedures adopted by the authorized entity’s governing board.
(8) The written bylaws, policies, or procedures of any professional review committee for persons licensed under article 240 of this title 12 or advanced practice registered nurses must provide for at least the following:
(a)(I) Except as provided in subsection (8)(a)(II) of this section, if the findings of any investigation indicate that a person licensed under article 240 of this title 12 or an advanced practice registered nurse who is the subject of the investigation is lacking in qualifications or competency, has provided substandard or inappropriate patient care, or has exhibited inappropriate professional conduct and the professional review committee takes or recommends an action to adversely affect the person’s membership, affiliation, or privileges with the authorized entity, the professional review committee shall hold a hearing to consider the findings and recommendations unless the person waives, in writing, the right to a hearing or is given notice of a hearing and fails to appear.
(II) If the professional review committee is submitting its findings and recommendations to another professional review committee for review, only one hearing is necessary prior to any appeal before the governing board.
(b) A person who has participated in the course of an investigation is disqualified as a member of the professional review committee that conducts a hearing pursuant to subsection (8)(a) of this section, but the person may participate as a witness in the hearing.
(c) The authorized entity shall give to the subject of any investigation under this subsection (8) reasonable notice of the hearing and of any finding or recommendation that would adversely affect the person’s membership, affiliation, or privileges with the authorized entity, and the subject of the investigation has a right to be present, to be represented by legal counsel at the hearing, and to offer evidence in the person’s own behalf.
(d) After the hearing, the professional review committee that conducted the hearing shall make any recommendations it deems necessary to the governing board, unless otherwise provided by federal law or regulation.
(e) The professional review committee shall give a copy of the recommendations to the subject of the investigation, who then has the right to appeal to the governing board to which the recommendations are made with regard to any finding or recommendation that would adversely affect his or her membership, affiliation, or privileges with the authorized entity.
(9)(a) All governing boards shall adopt written bylaws, policies, or procedures under which a person who is licensed under article 240 of this title 12 or is an advanced practice registered nurse and who is the subject of an adverse recommendation by a professional review committee may appeal to the governing board following a hearing in accordance with subsection (8) of this section. The bylaws, policies, or procedures must provide that the person be given reasonable notice of his or her right to appeal and, unless waived by the person, has the right to appear before the governing board, to be represented by legal counsel, and to offer the argument on the record that the person deems appropriate.
(b) The bylaws may provide that a committee of not fewer than three members of the governing board may hear the appeal. Also, the bylaws may allow for an appeal to be heard by an independent third party designated by a governing board under this subsection (9)(b).
(10) All governing boards that are required to report their final actions to the medical board or the nursing board, as appropriate, are not otherwise relieved of their obligations by virtue of this part 2.
(11)(a) Except as specified in subsection (11)(b) of this section, the records of an authorized entity, its professional review committee, and its governing board are not subject to subpoena or discovery and are not admissible in any civil suit.
(b) Subject to subsection (14) of this section, the records are subject to subpoena and available for use:
(I) By either party in an appeal or de novo proceeding brought pursuant to this part 2;
(II) By a person licensed under article 240 of this title 12 or an advanced practice registered nurse in a suit seeking judicial review of an action by the governing board;
(III) By the department of public health and environment in accordance with its authority to issue or continue a health facility license or certification for an authorized entity;
(IV) By CMS in accordance with its authority over federal health care program participation by an authorized entity;
(V) By an authorized entity or governing board seeking judicial review;
(VI) By the medical board within the scope of its authority over licensed physicians and physician assistants; and
(VII) By the nursing board within the scope of its authority over advanced practice registered nurses.
(12)(a) Except as provided in subsection (12)(b) of this section, the records of an authorized entity or its professional review committee may be disclosed to:
(I) The medical board, as requested by the medical board acting within the scope of its authority or as required or appropriate under this part 2 or article 240 of this title 12;
(II) The nursing board, as requested by the nursing board acting within the scope of its authority or as required or appropriate under this part 2 or part 1 of article 255 of this title 12;
(III) The department of public health and environment acting within the scope of its health facility licensing authority or as the agent of CMS;
(IV) CMS, in connection with the survey and certification processes for federal health care program participation by an authorized entity; and
(V) The Joint Commission or other entity granted deeming authority by CMS, in connection with a survey or review for accreditation.
(b) The medical board, nursing board, and department of public health and environment shall not make further disclosures of any records disclosed by an authorized entity or its professional review committee under this section.
(13) The records of an authorized entity or its professional review committee or governing board may be shared by and among authorized entities and their professional review committees and governing boards concerning the competence of, professional conduct of, or the quality and appropriateness of patient care provided by, a health care provider who seeks to subject himself or herself to, or is currently subject to, the authority of the authorized entity.
(14) Responding to a subpoena or disclosing or sharing of otherwise privileged records and information pursuant to subsection (11), (12), or (13) of this section does not constitute a waiver of the privilege specified in subsection (11)(a) of this section or a violation of the confidentiality requirements of subsection (16) of this section. Records provided to any governmental agency, including the department of public health and environment, the medical board, and the nursing board pursuant to subsection (11) or (12) of this section are not public records subject to the “Colorado Open Records Act”, part 2 of article 72 of title 24. A person providing the records to an authorized entity or its professional review committee or governing board, the department of public health and environment, the medical board, the nursing board, CMS, the Joint Commission, or other governmental agency is entitled to the same immunity from liability as provided under
section 12-30-207 for the disclosure of the records.
(15) Investigations, examinations, hearings, meetings, and other proceedings of a professional review committee or governing board conducted pursuant to this part 2 are exempt from any law requiring that proceedings be conducted publicly or that the records, including any minutes, be open to public inspection.
(16) Except as otherwise provided in subsection (11), (12), or (13) of this section, all proceedings, recommendations, records, and reports involving professional review committees or governing boards are confidential.
(17) A professional review committee or governing board that is constituted and conducts its reviews and activities in accordance with this part 2 is not an unlawful conspiracy in violation of
section 6-4-104 or
6-4-105.
(18)(a) Original source documents are not protected from subpoena, discovery, or use in any civil action merely because they were considered by or presented to a professional review committee. Original source documents are subject to subpoena or discovery only from the original sources and are protected from subpoena or discovery from the professional review files of a professional review committee of an authorized entity except as provided below:
(I) Upon subpoena or request for discovery for original source documents, an authorized entity shall provide a log of all original source documents contained in the authorized entity’s professional review files including the source and nature of each original source document.
(II) The individual patient in interest in a civil action by such person, next friend, or legal representative may subpoena or seek discovery of any original source document identified on the authorized entity’s professional review committee log only if the original source document was not produced in response to a prior subpoena or discovery request to the original source.
(b) This subsection (18) does not relieve any party of their obligation under the Colorado rules of civil procedure.
C.R.S.A. §12-30-205. Hospital professional review committees (Effective: May 25, 2023) (Formerly cited as CO ST § 12-36.5-104.4)
(1) The quality and appropriateness of patient care rendered by persons licensed under article 240 of this title 12, advanced practice registered nurses, and other licensed health care professionals so influence the total quality of patient care that a review of care provided in a hospital is ineffective without concomitantly reviewing the overall competence of, professional conduct of, or the quality and appropriateness of care rendered by, these persons.
(2)(a)(I) Whenever a professional review committee created pursuant to
section 12-30-204 reasonably believes that the quality or appropriateness of care provided by other licensed health care professionals may have adversely affected the outcome of patient care, the professional review committee shall:
(A) Refer the matter to a hospital quality management program created pursuant to
section 25-3-109; or
(B) Consult with a representative of the other licensed health care professional’s profession.
(II) A professional review committee established pursuant to this part 2 may meet and act in collaboration with a hospital quality management program established pursuant to
section 25-3-109.
(b) All matters considered in collaboration with or referred to a committee pursuant to this subsection (2) and all records and proceedings related thereto shall remain confidential, and the committee members, governing board, witnesses, and complainants are subject to the immunities and privileges as set forth in this part 2.
(3) Nothing in this section is deemed to extend the authority or jurisdiction of the medical board to any individual not otherwise subject to the jurisdiction of the board.
C.R.S.A. §12-30-206. Governing boards to register with division — annual reports — aggregation and publication of data — definition — rules (Effective: May 25, 2023) (Formerly cited as CO ST § 12-36.5-104.6)
(1) As used in this section, “adversely affecting” has the same meaning as set forth in
45 CFR 60.3; except that it does not include a precautionary suspension or any professional review action affecting, for a period of thirty or fewer days, a person licensed under article 240 of this title 12 or an advanced practice nurse.
(2) Each governing board that establishes or uses one or more professional review committees to review the practice of persons licensed under article 240 of this title 12 or of advanced practice nurses shall:
(a) Register with the division in a form satisfactory to the division on or before July 1, 2013, if the governing board has one or more existing professional review committees, or, if the governing board first establishes a professional review committee on or after July 1, 2013, within thirty days after approving the written bylaws, policies, or procedures for the professional review committee;
(a.5) Update the governing board’s information, as specified by the division by rule in accordance with subsection (4)(a) of this section, with the division annually, including whether the governing board is currently engaged in a professional review activity or intends to engage in a professional review activity in the future;
(b) In addition to any other state or federal reporting requirements:
(I) Report annually to the medical board, in a form satisfactory to the medical board, the number of final professional review actions in each of the following categories relating to individuals licensed under article 240 of this title 12:
(A) Adversely affecting the individual;
(B) In which an authorized entity accepted the individual’s surrender of clinical privileges, membership, or affiliation while the individual was under investigation;
(C) In which an authorized entity accepted the individual’s surrender of clinical privileges, membership, or affiliation in return for not conducting an investigation; and
(D) In which the professional review committee made recommendations regarding the individual following a hearing pursuant to
section 12-30-204(8)(d);
(II) Report annually to the nursing board, in a form satisfactory to the nursing board, the number of final professional review actions in each of the following categories relating to advanced practice nurses:
(A) Adversely affecting the individual;
(B) In which an authorized entity accepted the individual’s surrender of clinical privileges, membership, or affiliation while the individual was under investigation;
(C) In which an authorized entity accepted the individual’s surrender of clinical privileges, membership, or affiliation in return for not conducting an investigation; and
(D) In which the professional review committee made recommendations regarding the individual following a hearing pursuant to
section 12-30-204(8)(d);
(c)(I) Report to the division, in a de-identified manner, on its professional review activities during the immediately preceding calendar year in a form satisfactory to the division. These reports must include aggregate data, which is limited to the following:
(A) The number of investigations completed during the year;
(B) The number of investigations that resulted in no action;
(C) The number of investigations that resulted in written involuntary requirements for improvement sent to the subject of the investigation by the authorized entity; and
(D) The number of investigations that resulted in written agreements for improvement between the subject of the investigation and the authorized entity.
(II)(A) The medical board and the nursing board shall forward the reports received pursuant to subsections (2)(b)(I) and (2)(b)(II) of this section, respectively, to the division in a de-identified manner.
(B) The division shall not publish any information identifying the governing board or authorized entity making a report under subsection (2)(b) of this section or this subsection (2)(c), and the reports and information are not public records under the “Colorado Open Records Act”, part 2 of article 72 of title 24.
(III) Reports submitted pursuant to this subsection (2)(c) must include only investigations in which no final action adversely affecting the subject of the investigation was taken or recommended.
(IV) The identity of the governing board reporting the data and the data reported pursuant to this subsection (2)(c) or subsection (2)(b) of this section may be known to the division.
(3)(a) The division shall publish the data provided pursuant to subsections (2)(b) and (2)(c) of this section in aggregate form and without individually identifiable information concerning the governing board, the authorized entity, or any person who was subject to review and is licensed under article 240 of this title 12 or is an advanced practice nurse.
(b) The division shall maintain and shall publish online, through its website, a current list of all governing boards that are registered in accordance with this section and that otherwise are in compliance with this part 2.
(a) Shall adopt rules to:
(I) Implement this section;
(II) Determine the de-identified information regarding investigations and outcomes a governing board is required to report; and
(III) Establish a process to remove a governing board from the registry when the governing board is no longer required to register with the division pursuant to this section; and
(b) May collect a reasonable registration fee to recover its direct and indirect costs of administering the registration and publication systems required by this section.
(5) For purposes of this section, an investigation occurs when the authorized entity or its professional review committee notifies the subject of the investigation in writing that an investigation has commenced.
(6) The medical board and the nursing board shall not initiate an investigation or issue a subpoena based solely on the data reported pursuant to subsection (2)(c) of this section.
(7)(a) A governing board that fails to register with the division pursuant to subsection (2)(a) of this section is not entitled to any immunity afforded under this part 2 until the date that the governing board so registers. A governing board’s failure to register does not affect any immunity, confidentiality, or privilege afforded to an individual participating in professional review activities.
(b) A governing board’s failure to report as required by this section does not affect any immunity, confidentiality, or privilege afforded to the governing board under this part 2.
C.R.S.A. §12-30-207. Immunity from liability (Effective: May 25, 2023) (Formerly cited as CO ST § 12-36.5-105)
(1) A member of a professional review committee, a governing board or any committee or third party designated by the governing board under
section 12-30-204(9)(b) and any person serving on the staff of that committee, board, panel, or third party, a witness or consultant before a professional review committee, and any person who files a complaint or otherwise participates in the professional review process, is immune from suit and liability for damages in any civil or criminal action, including antitrust actions, brought by a person licensed under article 240 of this title 12 or an advanced practice nurse who is the subject of the review by the professional review committee unless, in connection with the professional review process, the person provided false information and knew that the information was false.
(2) The governing board and the authorized entity that has established a professional review committee pursuant to
section 12-30-204 is immune from suit and liability for damages in any civil or criminal action, including antitrust actions, brought by a person licensed under article 240 of this title 12 or an advanced practice nurse who is the subject of the review by such professional review committee if the professional review action was taken within the scope of the professional review process and was taken:
(a) In the objectively reasonable belief that the action was in the furtherance of quality health care;
(b) After an objectively reasonable effort to obtain the facts of the matter;
(c) In the objectively reasonable belief that the action taken was warranted by the facts; and
(d) In accordance with procedures that, under the circumstances, were fair to the person licensed under article 240 of this title 12 or the advanced practice nurse.
C.R.S.A. §12-30-208. Conformance with federal law and regulation — legislative declaration — rules — limitations on liability — definition (Effective: May 25, 2023) (Formerly cited as CO ST §§ 12-36.5-201, 12-36.5-202, 12-36.5-203)
(1) The general assembly hereby finds, determines, and declares that the enactment of this section is necessary in order for the state to comply with the provisions of the federal “Health Care Quality Improvement Act of 1986”, as amended,
42 U.S.C. secs. 11101 to
11152. It is the intent of the general assembly that the provisions of this section are to be interpreted as being complementary to the other provisions in this part 2. The provisions of this section are intended to be responsive to specific requirements of the federal “Health Care Quality Improvement Act of 1986”, as amended. If the provisions of this section conflict with the other provisions of this part 2, other than with respect to the specific requirements of the federal “Health Care Quality Improvement Act of 1986”, as amended, the other provisions of this part 2 prevail.
(2) The medical board and nursing board may promulgate rules to comply with the reporting requirements of the federal “Health Care Quality Improvement Act of 1986”, as amended, and may participate in the federal data bank.
(3)(a) The following persons are immune from suit and not liable for damages in any civil action with respect to their participation in, assistance to, or reporting of information to a professional review committee in connection with a professional review action in this state, and such persons are not liable for damages in a civil action with respect to their participation in, assistance to, or reporting of information to a professional review committee that meets the standards of and is in conformity with the federal “Health Care Quality Improvement Act of 1986”, as amended:
(I) An authorized entity, professional review committee, or governing board;
(II) Any person acting as a member of or staff to the authorized entity, professional review committee, or governing board;
(III) A witness, consultant, or other person who provided information to the authorized entity, professional review committee, or governing board; and
(IV) Any person who participates with or assists the professional review committee or governing board with respect to the professional review activities.
(b)(I) Notwithstanding subsection (3)(a) of this section, nothing in this section relieves an authorized entity that is a health care facility licensed or certified pursuant to part 1 of article 3 of title 25 or certified pursuant to
section 25-1.5-103 (1)(a)(II) of liability to an injured person or wrongful death claimant for the facility’s independent negligence in the credentialing or privileging process for a person licensed under article 240 of this title 12 or an advanced practice nurse who provided health care services for the injured or deceased person at the facility. For purposes of this subsection (3), the facility’s participation in the credentialing process or the privileging process does not constitute the corporate practice of medicine.
(II) Nothing in this subsection (3) affects the confidentiality or privilege of any records subject to
section 12-30-204(11) or of information obtained and maintained in accordance with a quality management program as described in
section 25-3-109. The exceptions to confidentiality or privilege as set forth in
sections 12-30-204(11) and
25-3-109(4) apply.
(III) This subsection (3)(b) applies to actions filed on or after July 1, 2012.
(c) For the purposes of this subsection (3), unless the context otherwise requires, “professional review action” means an action or recommendation of a professional review committee that is taken or made in the conduct of professional review activity and that is based on the quality and appropriateness of patient care provided by, or the competence or professional conduct of, an individual person licensed under article 240 of this title 12 or an advanced practice nurse, which action affects or may affect adversely the person’s clinical privileges of or membership in an authorized entity. “Professional review action” includes a formal decision by the professional review committee not to take an action or make a recommendation as provided in this subsection (3)(c) and also includes professional review activities relating to a professional review action. An action is not based upon the competence or professional conduct of a person if the action is primarily based on:
(I) The person’s association or lack of association with a professional society or association;
(II) The person’s fees or advertising or engaging in other competitive acts intended to solicit or retain business;
(III) The person’s association with, supervision of, delegation of authority to, support for, training of, or participation in a private group practice with a member or members of a particular class of health care practitioners or professionals;
(IV) The person’s participation in prepaid group health plans, salaried employment, or any other manner of delivering health services whether on a fee-for-service basis or other basis;
(V) Any other matter that does not relate to the quality and appropriateness of patient care provided by, or the competence or professional conduct of, a person licensed under article 240 of this title 12 or an advanced practice nurse.
C.R.S.A. §13-21-110. Medical committee — privileged communication — limitation on liability
(1) Any information, data, reports, or records made available to a utilization review committee of a hospital or other health care facility, as required by state or federal law, is confidential and shall be used by such committee and the members thereof only in the exercise of the proper functions of the committee. It shall not be a violation of a privileged communication for any physician, dentist, podiatrist, hospital, or other health care facility or person to furnish information, data, reports, or records to any such utilization review committee concerning any patient examined or treated by the same or confined in such hospital or facility, which information, data, reports, or records relate to the proper functions of the utilization review committee. No member of such a committee shall be liable for damages to or for any such patient by reason of recommendations made by the committee in the exercise of the proper function of the committee, except for willful or reckless disregard of the patient’s safety
(2) As used in this section, “utilization review committee” means a committee established for the purpose of evaluating the quantity, quality, and timeliness of health care services rendered under the “Colorado Medical Assistance Act” and in compliance with Titles XVIII and XIX of the federal “Social Security Act,” as amended.
(3) The privilege created by subsection (1) of this section shall not prevent any such information, data, reports, or records which have been made available to a utilization review committee from being admitted in evidence or otherwise made available for use in the review process referred to in section 13-90-107(1)(d)(III) and (1)(d)(IV).
C.R.S.A. §25-3-109. Quality management functions — confidentiality and immunity
(1) The general assembly hereby finds and declares that the implementation of quality management functions to evaluate and improve patient and resident care is essential to the operation of health care facilities licensed or certified by the department of public health and environment pursuant to section 25–1.5–103(1)(a). For this purpose, it is necessary that the collection of information and data by such licensed or certified health care facilities be reasonably unfettered so a complete and thorough evaluation and improvement of the quality of patient and resident care can be accomplished. To this end, quality management information relating to the evaluation or improvement of the quality of health care services shall be confidential, subject to the provisions of subsection (4) of this section, and persons performing such functions shall be granted qualified immunity. It is the intent of the general assembly that nothing in this section revise, amend, or alter article 240 or part 2 of article 30 of title 12.
(2) For purposes of this section, a “quality management program” means a program that includes quality assurance and risk management activities, the peer review of licensed health care professionals not otherwise provided for in part 2 of article 30 of title 12, and other quality management functions that are described by a facility in a quality management program approved by the department of public health and environment. Nothing in this section shall revise, amend, or alter article 240 or part 2 of article 30 of title 12.
(3) Except as otherwise provided in this section, any records, reports, or other information of a licensed or certified health care facility that are part of a quality management program designed to identify, evaluate, and reduce the risk of patient or resident injury associated with care or to improve the quality of patient care shall beconfidentialinformation; except that such information shall be subject to the provisions of subsection (4) of this section.
(4) The records, reports, and other information described in subsection (3) and subsection (5.5) of this section shall not be subject to subpoena or discoverable or admissible as evidence in any civil or administrative proceeding. No person who participates in the reporting, collection, evaluation, or use of such quality management information with regard to a specific circumstance shall testify thereon in any civil or administrative proceeding. However, this subsection (4) shall not apply to:
(a) Any civil or administrative proceeding, inspection, or investigation as otherwise provided by law by the department of public health and environment or other appropriate regulatory agency having jurisdiction for disciplinary or licensing sanctions;
(b) Persons giving testimony concerning facts of which they have personal knowledge acquired independently of the quality management information program or function;
(c) The availability, as provided by law or the rules of civil procedure, of factual information relating solely to the individual in interest in a civil suit by such person, next friend or legal representative. In no event shall such factual information include opinions or evaluations performed as a part of the quality management program.
(d) Persons giving testimony concerning an act or omission which they have observed or in which they participated, notwithstanding any participation by them in the quality management program;
(e) Persons giving testimony concerning facts they have recorded in a medical record relating solely to the individual in interest in a civil suit by such person.
(5) Nothing in this section shall affect the voluntary release of any quality management record or information by a health care facility; except that no patient-identifying information shall be released without the patient’s consent.
(5.5)(a) The confidentiality of information provided for in this section shall in no way be impaired or otherwise adversely affected solely by reason of the submission of the information to a nongovernmental entity to conduct studies that evaluate, develop, and analyze information about health care operations, practices, or any other function of health care facilities. The records, reports, and other information collected or developed by a nongovernmental entity shall remain protected as provided in subsections (3) and (4) of this section. In order to adequately protect the confidentiality of such information, no findings, conclusions, or recommendations contained in such studies conducted by any such nongovernmental entity shall be deemed to establish a standard of care for health care facilities.
(b) For purposes of this subsection (5.5), “health care facility” includes a carrier as defined in section 10-16-102(8), C.R.S., and a healthcare practitioner licensed or certified pursuant to title 12, C.R.S.
(6) Any person who in good faith and within the scope of the functions of a quality management program participates in the reporting, collection, evaluation, or use of quality management information or performs other functions as part of a quality management program with regard to a specific circumstance shall be immune from suit in any civil action based on such functions brought by a health care provider or person to whom the quality information pertains. In no event shall this immunity apply to any negligent or intentional act or omission in the provision of care.
(7), (8) Deleted by Laws 1997, H.B.97-1298, § 2, eff. April 24, 1997.
(9) Nothing in this section shall be construed to limit any statutory or common law privilege, confidentiality, or immunity.
(10) Nothing in this section shall revise, amend, or alter the requirements of section 25-3-107.
(11) Deleted by Laws 1997, H.B.97-1298, § 2, eff. April 24, 1997.
(12) Nothing in this section shall affect a person’s access to his medical record as provided in section 25-1-801, nor shall it affect the right of any family member or any other person to obtain medical record information upon the consent of the patient or his authorized representative.